Ustekinumab (Anti-IL-12/23p40 Monoclonal Antibody) in Patients With Leukocyte Adhesion Deficiency Type 1 (LAD1) Who Have Inflammatory Pathology
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Ustekinumab
Related studies linked through entity extraction aliases.
An Early Access Program For Ustekinumab In Participants With Moderately To Severely Active Crohn's Disease
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Study to Characterize Profile of Participant With Psoriatic Arthritis Depending on Whether Their Disease is Managed by a Dermatologist or by a Rheumatologist, and Starting Ustekinumab
- Status
- COMPLETED
- Phase
- N/A
A Safety Study of Ustekinumab in the Treatment of Pediatric Participants Aged 6 Years and Older With Moderate to Severe Plaque Psoriasis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Impact of Concomitant MTX on Efficacy, Safety and Adherence of Ustekinumab-treatment in Patients With Active PsA
- Status
- COMPLETED
- Phase
- PHASE3
Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn's Disease Patients Treated With Ustekinumab
- Status
- COMPLETED
- Phase
- PHASE3
A Pharmacokinetic Study of Ustekinumab in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE1
Ustekinumab for the Treatment of Giant Cell Arteritis
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Ustekinumab (STELARA) for the Treatment of Active Sight-Threatening Uveitis (STAR Study)
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Pre-Clinical (Alzheimers) Diagnosis PCD = Optimum Outcomes OO
- Status
- UNKNOWN
- Phase
- N/A
Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate Broadlumab vs Placebo and Ustekinumab
- Status
- TERMINATED
- Phase
- PHASE3
Safety Study of BMS-986202 in Healthy Subjects and to Treat Psoriasis
- Status
- COMPLETED
- Phase
- PHASE1
The Difference of Microparticles in Patients With Psoriasis Vulgaris Who Received Stelara(Ustekinumab)
- Status
- UNKNOWN
- Phase
- PHASE4
BI 655066 (Risankizumab) Compared to Placebo and Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
BI 655066 Versus Placebo & Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Comparative Effectiveness of Psoriasis Treatments on Systemic Inflammation
- Status
- COMPLETED
- Phase
- N/A